New Frontiers in Health Policy: Speakers
Professor Fernando Manuel Ferreira Araújo
Dr Katharina Hauck
Professor Jean-Paul Moatti
Professor Guido Rasi
Professor Peter Smith
Professor Fernando Manuel Ferreira Araújo
Fernando Manuel Ferreira Araújo was born in Oporto, in 1966.
He has a PhD in medicine from the Faculty of Medicine of Oporto, and graduated in Medicine from the same Faculty.
Specialized in Immunohematology, with the degree of Consultant and the category of Senior Graduate Assistant, he owns Management Competencies in Health Services, recognized by the Portuguese Medical Association. He has also a post-graduation in Management from the Portuguese Catholic University.
He is Assistant Professor of the Faculty of Medicine of Oporto, he taught the discipline of Hematology, and in Masters Courses in Molecular Medicine and Molecular Medicine and Oncology and in Special Studies Cycles organized by the Faculty of Medicine of Oporto.
He had multiple responsibilities at the senior management level of health institutions such as Deputy of the Clinic Directorate of Hospital de São João, E.P.E, responsible for the Health Projects under “Saúde XXI” of Hospital de São João, E.P.E., Chairman of the Committee on Clinical Evaluation of the Information Systems of Hospital de São João, E.P.E., Coordinator of the North Maternal and Child Centre process, President of the National Commission for the Development of Ambulatory Surgery, Coordinator of the North Rehabilitation Centre process, Member of the Board of the North Regional Administration of Health – Vice-President and President).
He was member of the Advisory Council of the National Fight AIDS Commission, President of the Regional Commission for Women’s Health, Children and Adolescents of the North Regional Administration of Health, Chairman of the Regional Technical prenatal diagnosis of the North Regional Administration of Health, Coordinator of the working group responsible for preparing the Profile Assistance and the Functional Program of the Hospital de Amarante.
Ministry of Health representative in the definition of the health policy strategy in the North Region, under the Operational Programme ON.2 “The New North” QREN 2007-2013. Member of the Commission to evaluate the Boards of the EPE Hospitals, Coordinator of the Commission for the Hospital Reorganization in the Metropolitan Area of Oporto, member of the Advisory Board of the Portuguese Blood Institute, I.P. He was President of the Regional Pharmacy and Therapeutics Commission of the North Region and the Oncology North Region Committee.
Director of the Immunohematherapy Service of the Hospital de S. João, E.P.E., director of the Laboratory Medicine Center of the Hospital de S. João, E.P.E., and President of the Working Group responsible to draft the Charter for Health Care Equipment’s in Primary Care in Oporto Municipality. Co-wrote the rules of Directorate-General of Health “Diagnosis and Laboratory Screening for infection with Human Immunodeficiency Virus” and “Clinical Use of erythrocyte concentrate on Adult”, National Coordinator of the Clinical Trial RE-VERSE-AD.
Member of the National Council for the National Health Service of the Medical Association, President of the College’s Directorate of Immunohematherapy Specialty of the Medical Association, member of the Health Services Management Competence Directorate of the Medical Association.
Member of the Centre for Research in Technology and Information Systems in Health.
Co-author of more than 200 documents (including original articles and papers in the form of abstracts, and book chapters), published in indexed scientific journals. Reviewer of scientific papers – Expert Review of Molecular Diagnostics, Transfusion, Vox sanguinis, ABO, Portuguese Acta Médica.
Dr Nick Banatvala
Dr Nick Banatvala MBBS, MSc, MD, FRCP, FFPH is currently Senior Adviser to the Assistant Director General (Noncommunicable Diseases and Mental Health) at WHO in Geneva. He leads the Secretariat of the UN Interagency Task Force on the Prevention and control of NCDs which was established by the UN Secretary General in 2013. Nick also leads WHO’s global training programme to build capacity on NCDs for senior policy makers in middle and low-income countries.
Prior to this, Nick was Head of Global Affairs at the Department of Health in England where he led the development and implementation of the UK Government’s first-ever global health strategy, its strategy for working with WHO and the Department of Health’s bilateral engagement with emerging economies. Before that, he headed up DFID’s work on global health initiatives and scaling up health services. This included leading on the health inputs for the 2005 G8 Gleneagles communiqué and represented the UK on a number of international initiatives, including the Global Fund to Fight AIDS, TB and Malaria and GAVI. Prior to this, Nick worked for the UK’s Department for International Development on health and education programmes in Pakistan, Afghanistan and the Middle East. Nick has experience of the NGO sector, having worked with the UK aid agency Merlin on a number of development and humanitarian programmes.
Nick trained in paediatrics and infectious diseases before doing public health and epidemiologic research in the UK and CDC, Atlanta. Nick has held senior posts in UK public health. Nick has sat on government, non-government and academic boards, as well as national and international committees. He has undertaken consultancies for a number of agencies including the World Bank. He has published widely on a range of international public health issues.
Dr Laure de Preux, Associate Professor
Laure de Preux is health and environmental economist. Her research uses micro-econometrics, and quantitative policy analysis methods. She also has extensive expertise in the use of hospital and climate data. Her work has been published in Health Economics, the Journal of Public Economics and the American Economic Review among others.Laure joined Imperial College London in 2013 as a Research Associate, she is funded by the British Academy to investigate the impact of climate variability on health outcomes in the UK. She has been appointed to Assistant Professor at the Business School and will start in September 2016. Previously, she was a research officer at the Center for Economic Performance at the London School of Economics. In parallel, she obtained a PhD in Economics from the Centre for Health Economics at the University of York.
Dr Katharina Hauck
Katharina Hauck is a Senior Lecturer in Health Economics at the School of Public Health, Imperial College London. She is an expert in the empirical evaluation of health policy and the economics of infectious diseases, with specific research interests in the economics of HIV/AIDS, economic impact of epidemics, evaluation of complex public health and healthcare interventions, and the role of individuals’ behaviour in the transmission of infectious disease.
Professor Jean-Paul Moatti
Professor Jean-Paul Moatti has been appointed President and Director-general of the French National Research Institute for Sustainable Development (IRD) in 2015.
Throughout his career, Professor Moatti has been at the head of many national scientific bodies and was also a member of the national committee of the CNRS and of the governing board of Aix-Marseille University.
He has been member of the Advisory Committee for Health Research to WHO Director General (2007-2011), and he has held position as Counselor for Economic and Social Affairs of the Executive Director of the Global Fund against AIDS, Tuberculosis and Malaria (2008-2009).
He has been recently appointed by UN Secretary-General Ban KI-MOON among 14 other eminent scientists and experts to draft the 2019 edition of the quadrennial Global Sustainable Development Report (GSDR).
Professor Jean-Paul Moatti is the author of over 350 articles in scientific journals and publications, writing as much in the field of economic and social sciences as in biomedical and public health. Notably, he is co-author of the article published in Nature Medicine in 2003, which demonstrated for the first time not only the virological and clinical feasibility but also the economic feasibility of access to highly active antiretroviral therapies for HIV/Aids in developing countries. Jean-Paul Moatti is the author of several books, including Le principe de prévention. Le culte de la santé et ses dérives (“The principle of prevention. The cult of health and its excesses”, published in 2009 with the sociologist Patrick Peretti-Watel by Editions du Seuil).
Jean-Paul Moatti was granted the rank of knight of the Legion of Honour in January 2016.
Professor Franco Sassi
Franco Sassi holds a Chair in International Health Policy and Economics and is the Director of the Centre for Health Economics and Policy Innovation. He is also a Senior Health Economist at the Organisation for Economic Co-operation and Development – OECD, Paris (on leave) – where he developed and was responsible for the Organisation’s Public Health Programme. His work focuses on assessing the impacts of public policies to tackle major chronic diseases and their predisposing risk factors, including poor nutrition, physical inactivity, alcohol and tobacco use, and a range of environmental and social exposures.
Adam Wagstaff is Research Manager of the Human Development and Public Services team in the World Bank’s Development Research Group. He holds a DPhil in economics from the University of York. Before joining the World Bank, he was Professor of Economics at the University of Sussex. Adam was Associate Editor of the Journal of Health Economics for 20 years, and is President of the International Health Economics Association. His research interests are in public economics and development economics, with health and distributional issues being his main preoccupations. Within health, he has published extensively on inter alia: health financing and health insurance; provider payment reform; equality, equity and poverty; and the demand for and production of health. Outside health, he has published on efficiency measurement, the redistributive effect and sources of progressivity of the personal income tax, and the redistributive effect of economic growth. He also has an interest and has published in the field of bibliometrics.
Professor James Barlow
Dr Laure de Preux
Dr Pedro Rosa Dias
Professor James Stirling
Dr Richard Torbett
Professor James Barlow
James Barlow is a Professor of Technology and Innovation Management (Healthcare) and associate director of research and evaluation for Imperial College Health Partners. He also works with the executive boards for the NIHR Northwest London CLAHRC and the Department of Health Policy Innovation Research Unit. From 2006-2013 he was Principal Investigator and a director of the Health and Care Infrastructure Research and Innovation Centre (HaCIRIC).He previously held positions at the Science Policy Research Unit (University of Sussex), University of Westminster and the Policy Studies Institute. He has a PhD from the London School of Economics and a background in geography and economics.
Watch Professor Barlow’s TEDx talk on Searching for Sustainable Health Systems here.
Professor Adalberto Campos Fernandes
Adalberto Campos Fernandes was born in Lisbon, in 1958.
He has a PhD in Health Administration from Universidade de Lisboa, a Master’s degree in Public Health and Health Service Administration from the Universidade Nova de Lisboa and graduated in Medicine from Universidade de Lisboa.
He is a specialist in Public Health, holds the competences in Health Services Management and in Pharmaceutical Medicine by the Ordem dos Médicos, Postgraduate in Management of Health Units by the from Universidade Católica Portuguesa and in Senior Management of Health Institutions from IESE Business School.
He is a Professor at the National School of Public Health at Universidade Nova de Lisboa and has been involved in coordination and teaching at various university institutions in the areas of health management and administration.
He was Senior Manager in health institutions such as Hospital de Santa Maria, Hospital Pulido Valente, Centro Hospitalar Lisboa Norte, Hospital de Cascais, SAMS Prestação Integrada de Cuidados de Saúde.
He was member of the work group for the Reform of the Internal Organization of Portuguese Hospitals, of the coordination group of the Health Care Program, which was part of the National Health Plan 2012-2016, of the Trustees’ Council of Academic Center of Medicine of Lisbon, and of the board of the Association for the Innovation and Development in Health.
He is member of the Foundation to the National Health Service, of the general council of the Portuguese Association for Hospital Development, of the National Academy of Medicine of Portugal, of the general council of Universidade de Évora, and of the board of the College of Management Competencies of Health Services of Ordem dos Médicos.
He is author or co-author of several papers related to administration and management of health services. He is also a member of national and international associations and scientific societies.
Professor Carol Propper
Carol is a Professor of Economics and her research interests focus on the impact of incentives on the quality of health care delivery and health system productivity and, more widely, on the design and consequences of incentives within the public sector and the boundary between the state and private markets. In 2010 Carol was awarded a CBE for her services to social science. The accolade recognises Carol’s research into public economics and economics of health care as well as her work with colleagues from other social science and medical disciplines. In 2014 she was elected as a fellow of the British Academy.
Professor Peter Smith
Peter C. Smith is Emeritus Professor of Health Policy. He is a mathematics graduate from the University of Oxford, and started his academic career in the public health department at the University of Cambridge. He has worked and published in a number of disciplinary settings, including statistics, operational research and accountancy. However, his main work has been in the economics of health and the broader public services, and he was a previous Director of the Centre for Health Economics at the University of York. At Imperial he launched and co-directed the Centre for Health Policy in the Institute of Global Health Innovation. Peter has acted in numerous UK governmental advisory capacities. He has also advised many overseas governments and international agencies, including the World Health Organization, the International Monetary Fund, the World Bank, the European Commission and the Organization for Economic Cooperation and Development.
He continues to research actively on economic aspects of global health. Current interests include: health system performance assessment, with a particular focus on international comparison; measuring and improving health system productivity; and universal health coverage. He has published widely on these and related topics, including 12 books and over 150 peer-reviewed journal papers.
Professor Guido Rasi
Professor Guido Rasi began his second term as Executive Director of EMA on 16 November 2015.
From November 2014 to mid-November 2015, Professor Guido Rasi served as EMA’s Principal Adviser in Charge of Strategy.
From November 2011 to November 2014 he was the Executive Director of the European Medicines Agency and a member of its Management Board in the three years prior to this.
He was Director-General of the Italian Medicines Agency from 2008 to 2011 and member of the Management Board from 2004 and 2008.
He was made full professor of microbiology at the University of Rome ‘Tor Vergata’ in 2008.
From 2005 to 2008 he was Director of the Institute of Molecular Medicine of the National Research Council in Rome.
From 1990 to 2005 Professor Rasi worked at the Institute for Experimental Medicine of the National Research Council, Italy.
He had a teaching and research experience at the University of California, Berkeley in 1999.
Professor Rasi holds a degree in medicine and surgery, with specialisations in internal medicine, allergology and clinical immunology, from the University of Rome.
From 1978 to 1990, he worked as a physician in hospital, research and private practice. He is author of more than 100 scientific publications.
Prof Rasi was born in Padova, Italy and is married with two children.
Dr Richard Torbett
Executive Director, Commercial Policy: UK and International – Association of the British Pharmaceutical Industry (ABPI)
Richard Torbett joined ABPI in July 2015 and is responsible for: pricing and commercial policy (including the Pharmaceutical Pricing and Regulation Scheme – PPRS); Health Technology Assessment; as well as the organisation’s partnership activities with the NHS throughout the UK.
Richard has spent the last 11 years working in the pharmaceutical industry. Immediately prior to joining ABPI the was the Chief Economist at the European Federation of Pharmaceutical Industries and Associations (EFPIA) where he was responsible for strategy as well as economic analysis and EFPIA’s relations with international economic institutions. He also spent six years at Pfizer Inc., most recently as Senior Director and Head of International Affairs.
Prior to joining the pharmaceutical industry, Richard worked as a government economist. He was a Senior Economist at the Department of Trade and Industry (DTI) in the UK. As a Government official, he held a number of posts at DTI, Cabinet Office and the European Commission.
Richard regularly participates in the public policy debate on the future healthcare, innovation and the role of pharmaceuticals. Throughout his career Richard has also been involved in a number of policy negotiations, both from within Government and on behalf of the pharmaceutical industry. Most recently he has been involved with the negotiation of medicines framework agreements with a number of governments throughout the EU. He has also contributed to academic work on public finances and the relationship between health and economic growth.
Richard has degrees in economics from the University of Sussex and the University of Grenoble. He Completed his PhD at the Science Policy Research Unit (SPRU), University of Sussex in 2001.
Dr Melanie Bertram
Melanie Bertram is a health economist working for the Department of Health Systems Governance and Financing at the World Health Organization where she leads a work stream on Value for Money and Efficiency. Her work focusses on economics to support both short and long term health sector planning, priority setting and projections of future health needs. She is responsible for NCD economic analysis within the WHO-CHOICE programme, and in support of the Global Action Plan for Non-Communicable Diseases as well as methodological lead on the development of country investment cases for NCDs in collaboration with the United Nations Interagency Task Force on NCDs. In addition she is the department focal point for Health Technology Assessment, working with countries to develop evidence informed decision making processes which are bolstered by economic considerations.
Professor David Gann
Dr Marisa Miraldo
Professor Carol Propper
Professor Franco Sassi
Michael Borowitz is Chief Economist at the Global Fund (Geneva). He has a doctorate in health economics and public policy from the University of Chicago as well as an M.D. and MPH. He leads global fund work on innovative finance, pay for performance, and sustainability and transition
His previous position was at the OECD, as a Senior Health Economist working, among other things, on pay for performance, mental health, and waiting times. Prior to that we worked at UK Department of Health in strategy unit on mental health strategy; UK Department for International Development (DFID) on access to medicines; the World Bank on Indonesia and China; the Soros Foundation as head of health. He began his career working on US health reform and then US development assistance in former Soviet Union.
Professor David Gann
Professor David Gann CBE CEng FICE FCGI
David Gann is a university and business leader, strategist and advocate with extensive international experience in innovation and technology management. He is Imperial’s Vice-President (Innovation) and member of the College’s Executive Board.
David is Professor of Innovation and Technology Management with a PhD in Industrial Economics, a Chartered Civil Engineer, Fellow of the Institution of Civil Engineers, Honorary Fellow of the Royal College of Art and Fellow of the City & Guilds Institute.
His research spans strategy, management science and systems engineering, particularly on infrastructure for the digital economy.
David is experienced in mentoring start-ups, supporting fast growth technology businesses and developing long-term strategic partnerships with multinational technology corporations.
He is Chairman of the Smart London Board, reporting to the Mayor of London.
He is a non-executive director at Directa Plus plc, the world’s largest producer of pristine graphene. Industrial experience includes serving as Laing O’Rourke’s Group Executive for research and innovation, and developing Crossrail’s Innovation Strategy with Crossrail’s CEO.
Dr Marisa Miraldo, Associate Professor of Economics
Marisa has developed expertise in public policy and pharmaceutical economics by having participated in research projects commissioned by the Department of Health focusing on topics such as competition and regulation in secondary and primary care, competition between public and private providers and the impact of public policy on Pharmaceutical firms’ strategies.
She is particularly interested in regulation and competition in the health care sector and, more generally, in the public sector
Dr Pedro Rosa Dias, Associate Professor
Pedro Rosa Dias works on health economics in developing countries, inequalities in health and healthcare and the effects of educational policy on health outcomes. Before joining Imperial College London he held academic positions at the Universities of Sussex and York. Pedro has a PhD in Economics from the University of York and an MSc in Economics from the London School of Economics.
Professor Francisco Veloso
Imperial College London has named internationally renowned innovation scholar Professor Francisco Veloso the new Dean of its Business School.
Born in Lisbon, Professor Veloso completed an undergraduate degree in Physics Engineering, before receiving his PhD in Technology Management and Policy from MIT in 2001. In 2008 he was awarded the Alfred P. Sloan Industry Studies Fellowship for research on innovation in the auto sector.
Professor Veloso joins Imperial from the Católica Lisbon School of Business and Economics, Portugal’s leading business school, where he has served as Dean since 2012. Professor Veloso is a leading authority in Innovation and Entrepreneurship, whose research has focussed on how firms and regions develop and leverage science and technology for economic growth.
His work has included studies into the development of Silicon Valley and into the innovation and scientific impact of developing nations.
His leadership has helped steer the Católica Lisbon School to becoming an institution with international reach – now ranked among the top 25 Business Schools in Europe by The Financial Times. During his time as Dean, international students numbers have been multiplied several fold, while the School’s research presence in top international journals has doubled.
He retains an adjunct appointment at Carnegie Mellon University, USA, where he was tenured Full Professor earlier in his career. As a member of the Board of Directors of the Carnegie Mellon – Portugal Program he oversaw the establishment of a research funding initiative and dual PhD programs between Carnegie Mellon and several Portuguese universities.
Dr Kalipso Chalkidou
Kalipso Chalkidou is the director of the Global Health and Development group at Imperial College London, helping governments build technical and institutional capacity for using evidence to inform health policy as they move towards Universal Healthcare Coverage. She led the establishment of the international Decision Support Initiative (iDSI), a multi-country network working towards better health around the world through evidence-informed spending in healthcare in low to middle income countries, involved in national reforms and working with key organisations such as HITAP and CGD.
Professor James Stirling
Professor James Stirling CBE FRS FCGI became the first Provost of Imperial College London in August 2013.
Before joining Imperial, Professor Stirling was the Head of the Cavendish Laboratory at the University of Cambridge.
He completed an undergraduate degree in mathematics at Peterhouse, Cambridge, graduating with first class honours in 1975 and obtained his PhD in Theoretical Particle Physics in 1979.
After periods of research in the USA, Cambridge and the European Centre for Particle Physics (CERN) in Geneva, he was appointed to a lectureship at Durham in 1986. He was promoted to Senior Lecturer in 1989, to Reader in 1990 and to Professor in Mathematical Sciences and Physics in 1992.
In 2000 Professor Stirling became the first Director of the new Institute for Particle Physics Phenomenology (IPPP) at Durham University. From 2001 to 2003, he served as the first Chair of the PPARC Science Committee, the research council’s top-level scientific advisory committee.
In 2005 Professor Stirling was appointed Pro-Vice-Chancellor for Research at Durham University, a post which he held for three years before moving to Cambridge to take up the Jacksonian Professorship in September 2008.
In recognition of his contribution to particle physics research he was elected to the Fellowship of the Royal Society in May 1999. He was elected Fellow of The City and Guilds of London Institute in 2015. He was awarded a CBE in the 2006 New Years Honours list, for services to science.
He has been a member of the Physics Panel in two Research Assessment Exercises (2001 and 2008) and was Deputy Chair of the 2008 panel. He served on the Council of the Royal Society from 2007 to 2008, and as a member of the Council of the Science and Technology Facilities Council (STFC) from 2009-2015.
He is currently a member of the National Physical Laboratory Science & Technology Advisory Council, the Royal Albert Hall Council, Durham University Institute of Advance Study Advisory Committee and the Global Challenges Research Fund Strategic Advisory Group.